guardant health将参加即将举行的投资者会议。 Guardant Health, Inc.(纳斯达克:GH)是一家领先的精准肿瘤医疗公司,今日宣布公司将参加以下投资者会议。 ● 古根海姆首届医疗创新大会 Businesswire11/01 19:00 GH将于11月06日盘后发布财报,一图速览分析师最新预测 富途资讯11/01 09:00 摩根士丹利维持Guardant Health...
Guardant Health, Inc. Common Stock (GH) After-Hours 最新更新数据 Oct 29, 2024 08:00 PM ET. 本页面恢复更新时间 Oct 30, 2024 04:00 PM ET. Latest After-Hours Trades -> View Latest After-Hours Trades -> 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4...
Get Guardant Health real-time stock quotes, news, price and financial information from Macroaxis. Analyze Guardant Health Stock Investing. Consider adding Guardant Stock to your portfolios
Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company, has announced the pricing of an upsized underwritten public offering of 12,500,000 shares of its common stock at a public offering price of US$28.00 per share, before deducting underwriting discounts an...
NASDAQ: TMDX TransMedics Group Market Cap $4B Current Price $125.17 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services...
2024年8月7日盘后,美国肿瘤液态活检公司Guardant Health发布了2024Q2财报。财报显示,公司营收1.77亿美元,同比增长29.2%,环比增长5.2%。这也没毛病啊。哦,对,一定是亏损大幅提高了。2024Q2录得净亏损1.03亿美元,同比扩大41.0%。然而,事实上这是自2023Q4以来连续第三个季度的净亏损缩减,环比减少10.7%。看起来问题也...
Stock Information Financials Corporate Governance Resourcesshowing 1-3 of 3 Solutions Leadership GovernanceLatest News showing 1-3 of 3 October 30, 2024 Guardant Health Named to TIME’s List of the Best Inventions of 2024 October 28, 2024 Guardant Health to Share Data Supporting Critical Role of...
Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company, has announced the pricing of an upsized underwritten public offering of 12,500,000 shares of its common stock at a public offering price of US$28.00 per share, before deducting underwriting discounts and commis...